Patent US4484922A successfully refreshed from Google Patents.
US4484922A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Occular device
Assignee: Individual
•
Filing: 1981-06-25
•
Granted: 1984-11-27
•
Expires: 2001-06-25
Abstract
Abstract An ophthalmic delivery vehicle for dispensing therapeutic medications in the eye is comprised of a body defining a reservoir in which a therapeutic medication is stored and having a semipermeable skin or outer surface through which the medication is dispensed. The body has a frustospherical annular shape and has a size permitting the body to be inserted in the eye in circumscribing relationship with the corneal-scleral junction without intruding upon the junction. In the eye, the annular body extends in the posterior direction over the globe of the eye and into the upper and lower conjunctival sacs behind the upper and lower eyelids.
Inventors
- 👤 Peter L. Rosenwald
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 23:04
CPC Classifications
A; A61; A61F; A61F9/00; A61F9/0008; A61F9/0017
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
180 words
A method for delivering therapeutic medications directly to the cornea of a pre-selected eye comfortably and efficiently, comprising the steps of: A. forming a substantially frusto-spherical, continuous, annular-shaped body from non-allergenic material, insoluble in lacrimal fluids with a. the edges of said body being defined by two concentric circles, and b. the annular eye-contacting surface between said concentric circles substantially conforming to the overall curvature of the sclera of the pre-selected eye, B. forming the inside, edge-defining concentric circle of said annular-shaped body with a diameter slightly larger than the diameter of the corneal-scleral junction of the pre-selected eye; C. diffusing therapeutic medication throughout the annular body for retension therein and subsequent diffusion to the cornea of the pre-selected eye; and D. fitting the medication-containing annular body to the pre-selected eye with the inside circular edge thereof peripherally surrounding the corneal-scleral junction in close, juxtaposed spaced relationship, without intruding therein, whereby an ophthalmic delivery vehicle is attained which assures delivery of medication directly to the cornea of the eye, effectively and efficiently, while also being highly comfortable to the wearer.
Claim 2
Independent Claim
180 words
A method for delivering therapeutic medications directly to the cornea of a pre-selected eye comfortably and efficiently, comprising the steps of: A. forming a substantially frusto-spherical, continuous, annular-shaped body from non-allergenic material, insoluble in lacrimal fluids with a. the edges of said body being defined by two concentric circles, and b. the annular eye-contacting surface between said concentric circles substantially conforming to the overall curvature of the sclera of the pre-selected eye, B. forming the inside, edge-defining concentric circle of said annular-shaped body with a diameter slightly larger than the diameter of the corneal-scleral junction of the pre-selected eye; C. diffusing therapeutic medication throughout the annular body for retension therein and subsequent diffusion to the cornea of the pre-selected eye; and D. fitting the medication-containing annular body to the pre-selected eye with the inside circular edge thereof peripherally surrounding the corneal-scleral junction in close, juxtaposed spaced relationship, without intruding therein, whereby an ophthalmic delivery vehicle is attained which assures delivery of medication directly to the cornea of the eye, effectively and efficiently, while also being highly comfortable to the wearer.
Claim 3
Dependent Claim
49 words
The method defined in claim 1, comprising the additional step of E. forming the annular body with a width sufficient to contain the medication, provided said outside, edge-defining concentric circle comprises a diameter less than the arcuate distance between the upper and lower conjunctival sacs of the pre-selected eye.
Claim 4
Independent Claim
206 words
A method for delivering therapeutic medications directly to the cornea of a pre-selected eye comfortably and efficiently, comprising the steps of: A. forming a substantially frusto-spherical, continuous, annular-shaped body from non-allergenic material, insoluble in lacrimal fluids with a. the edges of said body being defined by two concentric circles, and b. the annular eye-contacting surface between said concentric circles substantially conforming to the overall curvature of the sclera of the pre-selected eye, B. forming the inside, edge-defining concentric circle of said annular-shaped body with a diameter substantially coinciding with the diameter of the corneal-scleral junction of the pre-selected eye; C. forming the outside, edge-defining concentric circle of said annular-shaped body with a diameter less than the arcuate distance between the upper and lower conjunctival sacs; D. diffusing therapeutic medication throughout the annual body for retension therein and subsequent diffusion to the cornea of the pre-selected eye; and E. fitting the medication-containing annular body to the pre-selected eye with the inside circular edge thereof peripherally surrounding the corneal-scleral junction in close, juxtaposed spaced relationship, without intruding therein, whereby an ophthalmic delivery vehicle is attained which assures delivery of medication directly to the cornea of the eye, effectively and efficiently, while also being highly comfortable to the wearer.
Claim 5
Independent Claim
206 words
A method for delivering therapeutic medications directly to the cornea of a pre-selected eye comfortably and efficiently, comprising the steps of: A. forming a substantially frusto-spherical, continuous, annular-shaped body from non-allergenic material, insoluble in lacrimal fluids with a. the edges of said body being defined by two concentric circles, and b. the annular eye-contacting surface between said concentric circles substantially conforming to the overall curvature of the sclera of the pre-selected eye, B. forming the inside, edge-defining concentric circle of said annular-shaped body with a diameter substantially coinciding with the diameter of the corneal-scleral junction of the pre-selected eye; C. forming the outside, edge-defining concentric circle of said annular-shaped body with a diameter less than the arcuate distance between the upper and lower conjunctival sacs; D. diffusing therapeutic medication throughout the annual body for retension therein and subsequent diffusion to the cornea of the pre-selected eye; and E. fitting the medication-containing annular body to the pre-selected eye with the inside circular edge thereof peripherally surrounding the corneal-scleral junction in close, juxtaposed spaced relationship, without intruding therein, whereby an ophthalmic delivery vehicle is attained which assures delivery of medication directly to the cornea of the eye, effectively and efficiently, while also being highly comfortable to the wearer.
References Cited (Backward Citations)
US3995635A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-11-27 | 1988-05-28 | 1988-11-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-11-27 | 1992-05-28 | 1992-11-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-11-27 | 1996-05-28 | 1996-11-27 | $7700.00 | Window Closed / Lapsed |